Guth has Friedreich’s Ataxia and chose to raise money at Happy Place Nutrition for Friedreich’s Ataxia Research Alliance ...

The global Friedreich’s ataxia market is experiencing notable growth, fueled by advancements in genetic research, enhanced diagnostic technologies, and increased awareness of this rare ...

On Nov. 4, a 5-year-old Appaloosa mare in Kiowa County, Oklahoma, tested positive for West Nile virus (WNV). The unvaccinated horse developed clinical signs on Oct. 20, including ataxia, loss of ...

Artios Pharma, which looking for newer targets that, like PARP inhibitors, affect the way tumors fix themselves, said its ...

Comedian Fiona Cauley talks about turning 29 years old with a Friedreich's ataxia diagnosis, navigating the airport with a ...

Friedreich ataxia is an autosomal-recessive, neurodegenerative disease that primarily affects the nervous system and heart. It was named after Nicolaus Friedreich, a Professor of Medicine in ...

After the FDA rejected its spinocerebellar ataxia treatment, Biohaven missed out on a $150 million payment from Oberland Capital. Now the company is reshuffling its pipeline to stay alive.

The FDA has issued a CRL to Biohaven regarding the NDA for troriluzole for the treatment of adults with spinocerebellar ataxia.

Larimar Therapeutics ( ($LRMR) ) has provided an update. On November 10, 2025, Larimar Therapeutics announced an updated slide presentation ...

Larimar Therapeutics, Inc. ( (LRMR)) has released its Q3 earnings. Here is a breakdown of the information Larimar Therapeutics, Inc. presented to its investors. Larimar Therapeutics, Inc. is a ...

The Sept. 27 fundraiser featured showstopping auction items, including bucket-list vacations and an autographed 20-year-old bottle of Pappy Van Winkle bourbon. Times Total Media Correspondent Anyone ...

Lexeo Therapeutics, Inc. surges after FDA trial alignment for LX2006 in Friedreich’s ataxia. Click for more on LXEO stock following its Q3 earnings release.